ArticleHematological oncology2019

Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome.

Christopher B Benton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.